Ascentage Pharma Group International (HKG:6855)
Hong Kong · Delayed Price · Currency is HKD 66.10
-1.60 (-2.36%)
Oct 28, 2025, 4:08 PM HKT
Ascentage Pharma Group International Employees
Ascentage Pharma Group International had 567 employees as of December 31, 2024. The number of employees decreased by 16 or -2.74% compared to the previous year.
Employees
567
Change (1Y)
-16
Growth (1Y)
-2.74%
Revenue / Employee
707.46K HKD
Profits / Employee
-2.10M HKD
Market Cap
24.33B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 567 | -16 | -2.74% |
| Dec 31, 2023 | 583 | 3 | 0.52% |
| Dec 31, 2022 | 580 | -33 | -5.38% |
| Dec 31, 2021 | 613 | 180 | 41.57% |
| Dec 31, 2020 | 433 | 23 | 5.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sino Biopharmaceutical | 24,379 |
| CSPC Pharmaceutical Group | 21,400 |
| WuXi Biologics | 12,575 |
| BeOne Medicines AG | 11,000 |
| Hansoh Pharmaceutical Group Company | 8,989 |
| Innovent Biologics | 5,659 |
| JD Health International | 3,564 |
| Akeso | 3,035 |
Ascentage Pharma Group International News
- 7 weeks ago - Ascentage Pharma Group International (AAPG) Presents At Citi's Biopharma Back To School Conference Transcript - Seeking Alpha
- 2 months ago - Ascentage Pharma Group International GAAP EPS of -$0.24, revenue of $32.6M - Seeking Alpha
- 2 months ago - Ascentage Pharma Group International (AAPG) Advances in Global Phase III Study for Higher-Risk ... - GuruFocus
- 4 months ago - Ascentage Pharma Group International Announces Key Executive Appointments | AAPG stock news - GuruFocus
- 7 months ago - Chinese Biotech Ascentage Pharma's Valuation Driven By Late-Stage De-Risked Assets: JPMorgan - Benzinga
- 7 months ago - Earnings Scheduled For March 27, 2025 - Benzinga
- 7 months ago - Ascentage Pharma Group International (AAPG) Showcases Innovative Cancer Therapies at AACR 2025 - GuruFocus
- 9 months ago - Takeda-backed Ascentage Pharma aims to raise $126 mln in US IPO - Reuters